Global Corticosteroids Therapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Glucocorticoids and Mineralocorticoids.

By Route of Administration;

Inhaled, Oral, Systemic, and Topical.

By Application;

Skin Allergies, Rhuematology Indications, Endocrinology, Acute Respiratory Diseases, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn346909904 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Corticosteroids Therapy Market (USD Million), 2021 - 2031

In the year 2024, the Global Corticosteroids Therapy Market was valued at USD 5,375.57 million. The size of this market is expected to increase to USD 7,016.94 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.9%.

The research published in BMC Infectious Diseases in May 2021 highlighted the efficacy of methylprednisolone, a corticosteroid, in hospitalized hypoxic COVID-19 patients, showing superior outcomes compared to dexamethasone. This increased usage of corticosteroids in COVID-19 treatment underscores the profound impact of the pandemic on the corticosteroid market, driving demand for these medications in managing COVID-19-related complications.

Beyond the pandemic's influence, several key factors contribute to the growth of the corticosteroid market. These include the rising incidence of chronic diseases, such as inflammatory conditions, autoimmune disorders, and respiratory illnesses like asthma and COPD. Additionally, the aging global population, characterized by a higher prevalence of chronic conditions requiring corticosteroid therapy, further propels market expansion. Moreover, significant investments in research and development fuel innovation in corticosteroid formulations, delivery methods, and therapeutic applications, enhancing treatment efficacy and patient outcomes. Collectively, these factors underscore the robust growth trajectory of the corticosteroid market amidst evolving healthcare landscapes and pandemic-induced challenges.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Global Corticosteroids Therapy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Chronic Disease Burden
        2. Expanding Applications in Rheumatology
        3. Advancements in Drug Delivery
      2. Restraints
        1. Side Effects and Long-Term Use Concerns
        2. Regulatory Stringency
      3. Opportunities
        1. Development of Biosimilars
        2. Combination Therapies
        3. Focus on Pediatric Formulations
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Corticosteroids Therapy Market, By Product, 2021 - 2031 (USD Million)
      1. Glucocorticoids
      2. Mineralocorticoids
    2. Global Corticosteroids Therapy Market, By Route of Administration, 2021 - 2031 (USD Million)
      1. Inhaled
      2. Oral
      3. Systemic
      4. Topical
    3. Global Corticosteroids Therapy Market, By Application, 2021 - 2031 (USD Million)
      1. Skin Allergies
      2. Rhuematology Indications
      3. Endocrinology
      4. Acute Respiratory Diseases
      5. Others
    4. Global Corticosteroids Therapy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Sumitomo
      2. Pfizer
      3. Novartis
      4. Merck
      5. Sanofi
  7. Analyst Views
  8. Future Outlook of the Market